Company / Operating Margin
bioAffinity Technologies, Inc. Operating Margin History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-95.6%
FY2025
5-year range
-45946.7% / -58.1%
FY2022-FY2025
Trend
+69.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -58.1% to -95.6% over the past 2 years.
Based on SEC 10-K filings.
-95.6% in FY2025 with a 3-year CAGR of +45851.1%.
Declined from -58.1% to -95.6% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- +45851.1pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, operating margin increased 69.6% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.25 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -95.6% | +69.6% |
| FY2024 | -314.8% | -441.6% |
| FY2023 | -58.1% | +99.9% |
| FY2022 | -45946.7% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026